Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 779 Lung Neoplasms 345 Ovarian Neoplasms 323 Breast Neoplasms 279 Fallopian Tube Neoplasms 159 Triple Negative Breast Neoplasms 145 Small Cell Lung Carcinoma 144 Neoplasms 137 Squamous Cell Carcinoma of Head and Neck 123 Carcinoma, Ovarian Epithelial 114 Neoplasm Metastasis 85 Head and Neck Neoplasms 80 Endometrial Neoplasms 76 Uterine Cervical Neoplasms 72 Esophageal Neoplasms 71 Adenocarcinoma of Lung 70 Neuroblastoma 55 Central Nervous System Neoplasms 53 Lymphoma, Large B-Cell, Diffuse 49 Carcinoma 49 Recurrence 48 Brain Neoplasms 48 Prostatic Neoplasms 44 Parkinson Disease 4, Autosomal Dominant Lewy Body 44 Urinary Bladder Neoplasms 42 Esophageal Squamous Cell Carcinoma 41 Lymphoma 39 Melanoma 35 Carcinoma, Squamous Cell 33 Stomach Neoplasms 31

Interventions

midostaurin 2 vandetanib 1 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Carboplatin × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡